With pets being considered more as loved family members, pet owners tend to take measures of long-term health care by using preventive care and specific nutrition for their animals. With traditional use of medications becoming less effective for diseases that pets have, the use of therapeutic diets has become common among veterinary doctors and pet owners in order to manage diseases in a holistic manner. Such diets are used to control diseases like obesity, kidney disease, diabetes, gastrointestinal problems, and food allergies, while at the same time boosting the health status of the pets. With the rising importance of nutrition in disease treatment and prevention, the demand for therapeutic pet food has increased rapidly.

As per SNS Insider, the Pet Therapeutic Diets Market was valued at USD 4.20 billion in 2024 and is expected to reach USD 7.47 billion by 2032, growing at a CAGR of 7.48% over the forecast period from 2025-2032. The market has been witnessing consistent growth owing to the increased adoption of pets, awareness regarding the importance of preventive pet care, veterinarian’s recommendation for therapeutic nutrition, and high demand for specialized dietary needs.

Gain Actionable Intelligence on the Pet Therapeutic Diet Market – Request a Sample Report

Pet Therapeutic Diets Market

Top 4 Leading Companies in the Pet Therapeutic Diet Market

1. Hill’s Pet Nutrition

Hill pet

Hill's Pet Nutrition has been known for its science-backed therapeutic formulations in consultation with veterinarians and experts on nutrition. The range of Prescription Diet caters to a host of medical problems including obesity, digestive issues, kidney conditions, urinary tract and dermatological problems in dogs and cats. In February 2025, Prescription Diet Derm Complete was launched by the company containing bioactive compounds and Omega-3 fatty acids which can decrease chances of allergic reactions. Consistent investments made in the field of veterinary research have helped in making Hill's a worldwide leader in the clinical pet nutrition industry.

Key Strengths

  • Extensive prescription diet portfolio
  • Strong veterinary partnerships
  • Advanced nutritional research
  • Global distribution network

2. Royal Canin

Royal canin

Royal Canin is renowned for its customized nutrition according to specific breed, age, size, and even specific illnesses. Their specialized products are widely used among the veterinarians' recommendations to treat renal failure, digestive problems, obesity control, and urogenital diseases. Royal Canin is constantly developing its custom-made nutrition programs and applying scientific research to the development of products.

Key Strengths

  • Breed-specific nutrition expertise
  • Veterinary-exclusive product range
  • Strong clinical research
  • Global brand recognition

3. Purina Pro Plan Veterinary Diets

Purina

Purina Pro Plan Veterinary Diets provides specific nutritional products meant to help animals suffering from various health problems. Among other products offered by this company, one can find diets aimed at treating diabetes, problems with digestion, kidneys, food sensitivity, and weight loss. Purina Pro Plan Veterinary Diets keeps improving its products using modern nutritional science and educating veterinarians in preventive nutrition.

Key Strengths

  • Broad therapeutic nutrition portfolio
  • Advanced nutritional formulations
  • Strong veterinary engagement
  • Global manufacturing capabilities

4. Blue Buffalo

Blue Buffalo

The Blue Buffalo Company has successfully positioned itself in the field of premium pet nutrition with its natural formulations and dietary needs for pets based on veterinarians' prescription. The company is concerned about the wellbeing of pets' digestive system, immunity, weight management and general health. In January 2025, the Blue Buffalo Company has reformulated its GI Gastrointestinal Support Dog Food with increased digestibility and antioxidants.

Key Strengths

  • Premium natural ingredients
  • Digestive health expertise
  • Growing veterinary nutrition portfolio
  • Strong consumer brand

What is Driving the Future of Pet Therapeutic Diet Market?

The prevention of health problems has emerged as a very powerful driver of growth for the industry of pet therapeutic diets. Instead of resorting to treatment only when health problems become more serious, veterinarians now advise nutritional management of chronic diseases through special diet plans. As per the industry research, 72 percent of pet owners in the United States prefer therapeutic diets for chronic diseases.

Obesity among companion animals is increasingly becoming a problem and therefore, providing great potential for growth within the pet therapeutic diet market. Currently, more than 60% of the dogs and 55% of cats in the United States are considered to be either overweight or obese. The increasing need for weight control diets is contributing towards the continued growth of the market as the diets help in achieving weight reduction. On the other hand, there has been an increasing number of cases of chronic illnesses such as renal diseases, digestive ailments, food sensitivities and urinary tract diseases. This situation is promoting the growth of personalized therapeutic nutrition in the market.

In recent years, digital transformation has become a crucial aspect of changing the pet therapeutic diet market by ensuring better availability of veterinary care and customized nutrition. The increased use of telemedicine consultations, internet veterinary services, subscription models of pet nutrition and growth in e-commerce have made it possible to provide therapeutic diets to the pet owners all over the world. Digital channels also help in providing personalized nutrition advice to pets, ensuring compliance, and improving veterinarian-pet owner relationship. Moreover, ongoing advancements in nutrition and veterinary sciences make it possible for producers to create highly effective diets that are specifically designed for certain medical conditions.

Regional Market Outlook

The North American region was still the largest market in 2024, comprising 41.60% of total revenues. Good veterinary support, high awareness of preventive healthcare for pets, usage of premium pet food, and high expenditures on well-being of companion animals have been sustaining the dominance of the region. The U.S. dominates the region, which has strong veterinary recommendation of therapeutic pet food for obesity, kidney disease, gastrointestinal problems, among others.

The Asia Pacific region is anticipated to demonstrate the highest rate of growth up until 2032 owing to the increasing prevalence of pet ownership, high disposable income, urbanization trends and growing consciousness regarding specialized nutrition for pets. In China, India, Japan and South Korea, there is an increasingly fast-growing demand for premium pet food along with the expansion in veterinary services and digital health care solutions for pets. Europe also continues to be in a favorable market position due to these factors.

The Road Ahead

Future growth and development in the Pet Therapeutic Diet Market will be influenced by personalized nutrition and precision veterinary medicine. Artificial intelligence and the study of the microbiome, digital health monitoring, and nutritional recommendations based on data science are all expected to change the way that therapeutic nutrition is used for disease prevention and overall pet health. With increasing proactivity of pet owners with regard to healthcare, demand for specific condition-based diet products will increase.

Prominent players such as Hill’s Pet Nutrition, Royal Canin, Purina Pro Plan Veterinary Diets, Blue Buffalo, Virbac, and Farmina Vet Life keep innovating in nutrition and collaborations with veterinarians and developing premium products. The emphasis by these players on scientifically proven therapeutic diets, individualized treatment, and preventive care is anticipated to further build up the competitive environment and pave the way for the success of the Pet Therapeutic Diet Market.

Parry Kardani

Parry Kardani is an experienced Research Analyst specializing in market research, business intelligence, and strategic industry analysis within the Healthcare sector. She possesses strong expertise in evaluating healthcare technologies, medical devices, diagnostics, pharmaceuticals, biotechnology, digital health solutions, healthcare IT, and emerging therapeutic innovations across global markets. Her core competencies include market sizing and forecasting, competitive benchmarking, value chain and supply chain analysis, regulatory and reimbursement assessment, technology evaluation, demand-supply analysis, and healthcare industry trend monitoring. With a strong analytical approach and deep understanding of healthcare market dynamics, she supports organizations in identifying growth opportunities, assessing competitive landscapes, and making informed strategic decisions in the rapidly evolving healthcare ecosystem.